货号 | 中文品名 | CAS No. | 别名 |
WT-DM-C20839 | CGS 9343B | 109826-27-9 | KW-5617 |
WT-DM-C20840 | Ilorasertib | 1227939-82-3 | ABT-348 |
WT-DM-C20841 | Alloxan (hydrate) | 2244-11-3 | |
WT-DM-C20842 | Nolatrexed (hydrochloride) | 152946-68-4 | AG337 |
WT-DM-C20843 | E3330 | 136164-66-4 | APX 3330 |
WT-DM-C20845 | WAY-600 | 1062159-35-6 | |
WT-DM-C20846 | ADTL-EI1712 | 2414916-45-1 | |
WT-DM-C20848 | HMN-214 | 173529-46-9 | IVX-214 |
WT-DM-C20850 | MB-05032 | 261365-11-1 | |
WT-DM-C20851 | CZ415 | 1429639-50-8 | |
WT-DM-C20853 | Sitravatinib | 1123837-84-2 | MGCD-516 |
WT-DM-C20855 | RG-7112 | 939981-39-2 | RO5045337 |
WT-DM-C20857 | SMIFH2 | 340316-62-3 | |
WT-DM-C20858 | IPI-549 | 1693758-51-8 | |
WT-DM-C20859 | RMC-4550 | 2172651-73-7 | |
WT-DM-C20861 | Febuxostat Acyl Glucuronide | 1351692-92-6 | |
WT-DM-C20863 | Quazinone | 70018-51-8 | Ro 13-6438 |
WT-DM-C20866 | Ibuprofen Carboxylic Acid | 15935-54-3 | Carboxyibuprofen |
WT-DM-C20868 | Vosaroxin | 175414-77-4 | SNS-595 |
WT-DM-C20869 | (±)-2-hydroxy Ibuprofen | 51146-55-5 | |
WT-DM-C20873 | NMS-1286937 | 1034616-18-6 | NMS-P937 |
WT-DM-C20874 | NIH 12848 | 959551-10-1 | |
WT-DM-C20875 | STO-609 | 52029-86-4 | |
WT-DM-C20876 | AV-412 | 451493-31-5 | MP-412 |
WT-DM-C20877 | SKPin C1 | 432001-69-9 | |
WT-DM-C20878 | Valemetostat | 1809336-39-7 | DS-3201b |
WT-DM-C20880 | Autophinib | 1644443-47-9 | |
WT-DM-C20881 | NCL-00017509 | 1507367-00-1 | |
WT-DM-C20882 | NCGC00244536 | 2003260-55-5 | |
WT-DM-C20883 | Orlistat Degradation Product (sodium salt) | | |
WT-DM-C20884 | eCF506 | 1914078-41-3 | |
WT-DM-C20885 | DS-437 | 1674364-87-4 | |
WT-DM-C20886 | Withanolide B | 56973-41-2 | |
WT-DM-C20887 | ACHP | 406208-42-2 | |
WT-DM-C20888 | 3,5-Dinitrocatechol | 7659-29-2 | OR-486 |
WT-DM-C20889 | CVT-12012 | 1018675-35-8 | |
WT-DM-C20890 | ERGi-USU | 1147-56-4 | NSC 139021 |
WT-DM-C20891 | Zanubrutinib | 1691249-45-2 | BGB-3111 |
WT-DM-C20892 | Territrem B | 70407-20-4 | |
WT-DM-C20893 | DAPH | 145915-58-8 | CGP 52411 |
WT-DM-C20894 | Takinib | 1111556-37-6 | |
WT-DM-C20897 | IL-4 Inhibitor | 1332184-63-0 | |
WT-DM-C20898 | CH5132799 | 1007207-67-1 | |
WT-DM-C20899 | Varlitinib | 845272-21-1 | ARRY-334543 |
WT-DM-C20900 | MRTX-849 | 2326521-71-3 | |
WT-DM-C20902 | Glumetinib | 1642581-63-2 | SCC244 |
WT-DM-C20903 | ZL0420 | 2229039-45-4 | |
WT-DM-C20904 | p-APMSF (hydrochloride) | 74938-88-8 | (p-Amidinophenyl)methanesulfonyl Fluoride |
WT-DM-C20905 | Zopolrestat | 110703-94-1 | |
WT-DM-C20907 | IACS-010759 | 1570496-34-2 | |
WT-DM-C20908 | LB-100 | 1632032-53-1 | |
WT-DM-C20911 | Talabostat (mesylate) | 150080-09-4 | Val-boro-Pro |
WT-DM-C20912 | N-Phenylthiourea | 103-85-5 | 1-Phenyl-2-thiourea |
WT-DM-C20913 | iFSP1 | 150651-39-1 | |
WT-DM-C20914 | C-178 | 329198-87-0 | |
WT-DM-C20915 | WM-1119 | 2055397-28-7 | |
WT-DM-C20916 | LMW-PTP Inhibitor I (hydrochloride) | 2310135-46-5 | LMPTP Inhibitor I |
WT-DM-C20917 | Guanoclor | 5001-32-1 | Guanochlor |
WT-DM-C20922 | TMI-005 | 287405-51-0 | Apratastat |
WT-DM-C20926 | ONT-093 | 216227-54-2 | OC 144093 |
WT-DM-C20930 | Gisadenafil (besylate) | 334827-98-4 | UK 369003 |
WT-DM-C20933 | Rubitecan | 91421-42-0 | 9-nitro-20(S)-Camptothecin |
WT-DM-C20934 | Cilomilast | 153259-65-5 | SB 207499 |
WT-DM-C20935 | AS-2863619 | 2241300-51-4 | |
WT-DM-C20939 | SD-06 | 271576-80-8 | SD-006 |
WT-DM-C20941 | Anlotinib (hydrochloride) | 1058157-76-8 | |
WT-DM-C20944 | USP7-USP47 Inhibitor | 1247825-37-1 | |
WT-DM-C20945 | 16F16 | 922507-80-0 | |
WT-DM-C20947 | CAIX Inhibitor S4 | 1330061-67-0 | |
WT-DM-C20949 | OUL35 | 6336-34-1 | NSC 39047 |
WT-DM-C20950 | Amfenac (sodium salt hydrate) | 61618-27-7 | |
WT-DM-C20951 | TFAP | 1011244-68-0 | |
WT-DM-C20953 | AEG 3482 | 63735-71-7 | |
WT-DM-C20958 | ASK1 Inhibitor 10 | 1005775-56-3 | |
WT-DM-C20959 | UNC2881 | 1493764-08-1 | |
WT-DM-C20961 | EML 425 | 1675821-32-5 | |
WT-DM-C20962 | HLM006474 | 353519-63-8 | |
WT-DM-C20963 | Sitagliptin N-Sulfate (sodium salt) | 2470126-25-9 | |
WT-DM-C20964 | (?)-Rolipram | 85416-75-7 | (R)-(–)-Rolipram |
WT-DM-C20965 | NI-42 | 1884640-99-6 | |
WT-DM-C20966 | THZ531 | 1702809-17-3 | |
WT-DM-C20967 | (S)-DO271 | 2301865-01-8 | |
WT-DM-C20968 | Belizatinib | 1357920-84-3 | TSR-011 |
WT-DM-C20971 | Vorasidenib | 1644545-52-7 | AG-881 |
WT-DM-C20975 | SPRi 3 | 1292285-54-1 | |
WT-DM-C20976 | T-863 | 701232-20-4 | |
WT-DM-C20977 | ZLD1039 | 1826865-46-6 | |
WT-DM-C20978 | CD73-IN-1 | 2132396-40-6 | |
WT-DM-C20979 | Rbin-1 | 328023-11-6 | Ribozinoindole-1 |
WT-DM-C20981 | Pantothenate Kinase Inhibitor | 902614-04-4 | PANKi |
WT-DM-C20982 | KW 2478 | 819812-04-9 | |
WT-DM-C20985 | Pitofenone (hydrochloride) | 1248-42-6 | |
WT-DM-C20986 | OSS-128167 | 887686-02-4 | |
WT-DM-C20987 | SH-4-54 | 1456632-40-8 | |
WT-DM-C20988 | Phenprocoumon | 435-97-2 | Ro 1-4849 |
WT-DM-C20991 | 4-IPP | 41270-96-6 | |
WT-DM-C20994 | EMD 638683 | 1181770-72-8 | |
WT-DM-C20995 | Dasatinib N-oxide | 910297-52-8 | |
WT-DM-C20996 | H3B-6527 | 1702259-66-2 | |
WT-DM-C20997 | 7-(β-Hydroxyethyl)theophylline | 519-37-9 | Etophylline |
WT-DM-C20998 | PDD00017273 | 1945950-21-9 | |
WT-DM-C20999 | FM-381 | 2226521-65-7 | |
WT-DM-C21000 | Tunicamycin 14:1 Mixture | C37H60N4O16 | |
WT-DM-C21004 | INF39 | 866028-26-4 | |
WT-DM-C21005 | Acalisib | 870281-34-8 | GS-9820 |
WT-DM-C21006 | VX-765 | 273404-37-8 | Belnacasan |
WT-DM-C21007 | THZ2 | 1604810-84-5 | |
WT-DM-C21009 | RK-287107 | 2171386-10-8 | |
WT-DM-C21011 | HAMNO | 138736-73-9 | |
WT-DM-C21012 | Ketorolac (calcium salt) | 167105-81-9 | |
WT-DM-C21014 | (R)-BAY-598 | 1906920-28-2 | |
WT-DM-C21016 | Nampt-IN-1 | 1698878-14-6 | LSN3154567 |
WT-DM-C21019 | CUDC-907 | 1339928-25-4 | |
WT-DM-C21020 | MSC2530818 | 1883423-59-3 | |
WT-DM-C21021 | Mirodenafil (hydrochloride) | 862189-96-6 | SK3530 |
WT-DM-C21023 | KO947 | 1695533-89-1 | |
WT-DM-C21025 | Brivanib Alaninate | 649735-63-7 | BMS 582664 |
WT-DM-C21026 | MC1742 | 1776116-74-5 | |
WT-DM-C21027 | NAP 226-90 | 139306-10-8 | |
WT-DM-C21028 | 6-Aminophenanthridine | 832-68-8 | 6AP |
WT-DM-C21029 | PCI-29732 | 330786-25-9 | |
WT-DM-C21031 | 4SC-202 | 1186222-89-8 | |
WT-DM-C21032 | Alrestatin | 51411-04-2 | AY 22284 |
WT-DM-C21033 | L-006,235 | 294623-49-7 | |
WT-DM-C21034 | ABC99 | 2331255-53-7 | |
WT-DM-C21035 | DMH4 | 515880-75-8 | |
WT-DM-C21036 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | | |
WT-DM-C21037 | Raltitrexed | 112887-68-0 | ICI-D 1694 |
WT-DM-C21038 | Lumiracoxib | 220991-20-8 | COX 189 |
WT-DM-C21039 | Lipoxygenin | 2247911-68-6 | |
WT-DM-C21040 | Caspase-9 Inhibitor III (trifluoroacetate salt) | | |
WT-DM-C21041 | IMR-1 | 310456-65-6 | Inhibitor of Mastermind Recruitment-1 |
WT-DM-C21042 | YM-976 | 191219-80-4 | |
WT-DM-C21043 | P053 | 2748196-63-4 | |
WT-DM-C21044 | IDO-IN-3 | 2070018-30-1 | |
WT-DM-C21045 | ITI214 | 1642303-38-5 | |
WT-DM-C21048 | Feprazone | 30748-29-9 | |
WT-DM-C21050 | Derazantinib | 1234356-69-4 | ARQ 087 |
WT-DM-C21051 | C527 | 192718-06-2 | |
WT-DM-C21052 | NGP-555 | 1304630-27-0 | |
WT-DM-C21053 | HPA-12 | 383418-30-2 | (1R,3S)-HPA-12 |
WT-DM-C21054 | Bufexamac | 2438-72-4 | |
WT-DM-C21056 | H-151 | 941987-60-6 | |
WT-DM-C21057 | Olprinone (hydrochloride) | 119615-63-3 | Loprinone |
WT-DM-C21058 | Eltenac | 72895-88-6 | |
WT-DM-C21059 | α-Hydroxyglutaric Acid | 2889-31-8 | 2-HG |
WT-DM-C21060 | GI 254023X | 260264-93-5 | GI 4023 |
WT-DM-C21063 | UM-164 | 903564-48-7 | |
WT-DM-C21064 | CU-76 | 2400954-58-5 | |
WT-DM-C21065 | MRX-2843 | 1429882-07-4 | |
WT-DM-C21066 | c-Kit-IN-1 | 1225278-16-9 | |
WT-DM-C21068 | Enoximone | 77671-31-9 | MDL 17043 |
WT-DM-C21070 | Voxtalisib | 934493-76-2 | SAR245409 |
WT-DM-C21071 | BP-1-102 | 1334493-07-0 | |
WT-DM-C21072 | XMD17-109 | 1435488-37-1 | ERK5-IN-1 |
WT-DM-C21073 | SHS4121705 | 2379550-82-8 | |
WT-DM-C21074 | CCCP | 555-60-2 | Carbonyl cyanide m-chlorophenyl hydrazone |
WT-DM-C21075 | A01 | 1007647-73-5 | |
WT-DM-C21076 | DS44960156 | 2361327-08-2 | |